Unknown

Dataset Information

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas.


ABSTRACT:

Purpose

Patients with metastatic or relapsed pediatric sarcomas receive cytotoxic regimens that induce high remission rates associated with profound lymphocyte depletion, but ultimately few survive long term. We administered adjuvant immunotherapy to patients with metastatic and recurrent pediatric sarcomas in an effort to improve outcomes.

Experimental design

Mononuclear cells were collected via apheresis, and tumor lysate was acquired via percutaneous biopsy at enrollment. Participants received standard antineoplastic therapy, followed by autologous lymphocytes, tumor lysate/keyhole limpet hemocyanin-pulsed dendritic cell vaccinations ± recombinant human IL7. Primary outcomes were toxicity and vaccine responses. Secondary outcomes were immune reconstitution, event-free sur

SUBMITTER: Merchant MS 

PROVIDER: S-EPMC7831150 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature